five

Dataset from Efficacy of Ustekinumab (Anti-IL-12/23) Followed by Abatacept (CTLA4-Ig) for the Treatment of Psoriasis Vulgaris (ITN059AI)

收藏
NIAID Data Ecosystem2026-05-10 收录
下载链接:
https://doi.org/10.25934/PR00009443
下载链接
链接失效反馈
官方服务:
资源简介:
The purpose of this study is to determine if the use of ustekinumab, followed by abatacept, will prevent relapse in people with moderate to severe plaque psoriasis.
创建时间:
2026-02-06
二维码
社区交流群
二维码
科研交流群
商业服务